Deadline: Ongoing
Solving Kids’ Cancer is inviting applicants through its Therapeutic Development Initiative (TDI) Platform for research on High-Impact Pediatric Cancer.
Solving Kids’ Cancer is a nonprofit organization with a track-record of funding novel clinical research for children diagnosed with high-risk solid tumors specifically neuroblastoma, brain tumors and sarcomas. The TDI is SKC’s strategic platform for the implementation of its research agenda. The TDI of SKC only supports clinical research. The organization specifically focuses on novel clinical studies for neuroblastoma, brain tumors and sarcomas. Organization may fund studies in which additional pediatric cancer types are included in the study protocol.
The TDI program funds Clinical Research Grants up to two years for promising therapeutic approaches with potential to significantly improve the treatment of pediatric cancer.
Funding Information
TDI Awards are funded in a range from $50,000 to $600,000 depending on the nature of the proposed project. No institutional overhead or indirect funding will be provided.
Eligibility Criteria
- SKC welcomes applications from researchers within or outside the United States.
- Prior work in cancer research is not a prerequisite for applying
- Research fellows applying for funding must identify a full-time institution faculty member with whom they are affiliated. Research fellows whose project is ultimately approved and funded will be expected to complete the proposed project
- Companies interested in support for clinical efforts in pediatrics are welcome to apply.
How to Apply
Interested applicants may apply online from the website, given at the end.
Note: Proposals received earlier have a greater chance of support based on the programming budget.
For more information, please visit Pediatric Cancer Research.
